Spermosens AB (publ) (NGM:SPERM)
Sweden · Delayed Price · Currency is SEK 0.0056
-0.0006 (-9.68%)
At close: Dec 17, 2025
Spermosens AB Company Description
Spermosens AB (publ) provides diagnostic health care products and services in Sweden.
The company offers devices for male infertility for fertility diagnostics and treatments for the IVF market.
It develops JUNO-Checked, a device that measures the binding between sperm and egg cell to enable individualized choice of fertility treatment based on measured binding.
Spermosens AB (publ) was incorporated in 2018 and is headquartered in Lund, Sweden.
Spermosens AB (publ)
| Country | Sweden |
| Founded | 2018 |
| Industry | Electromedical and Electrotherapeutic Apparatus |
| Employees | 4 |
| CEO | Tore Duvold |
Contact Details
Address: Medicon Village Lund, 223 81 Sweden | |
| Phone | 46 1 03 30 04 42 |
| Website | spermosens.com |
Stock Details
| Ticker Symbol | SPERM |
| Exchange | Nordic Growth Market |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Tore Duvold | Chief Executive Officer |
| Alexander Dahlquist | Chief Financial Officer |